— Know what they know.
Not Investment Advice

MRRCF OTC

Wayland Group Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +900.0% 1Y: +0.0% 3Y: +900.0% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $2121 mcap · 197M float · 0.0006% daily turnover

Balance Sheet Trends

Total Assets
$74M +305.7% ▲
Total Liabilities
$25M +22.2% ▲
Shareholders Equity
$49M +2134.8% ▲
Cash & Investments
$20M +62.4% ▲
Total Debt
$19M -1.0% ▼
Net Debt
-$917K -113.5% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2015FY2016FY2017
— Assets —
Cash$374$12M$20M
Short-Term Investments$0$0$0
Cash & ST Investments$374$12M$20M
Net Receivables$0$155K$3M
Inventory$0$702K$1M
Other Current Assets$0$190K$430K
Total Current Assets$5K$13M$24M
Property, Plant & Equip.$0$5M$23M
Goodwill & Intangibles$0$0$27M
Long-Term Investments$0$0$301K
Other Non-Current Assets$0$0$0
Total Non-Current Assets$0$5M$51M
Total Assets$5K$18M$74M
— Liabilities —
Accounts Payable$0$2M$7M
Short-Term Debt$290K$25M$0
Deferred Revenue$0$146K$33K
Other Current Liabilities$51K$318K$629K
Total Current Liabilities$341K$21M$6M
Long-Term Debt$0$0$19M
Other Non-Current Liab.$0$0$5M
Total Non-Current Liabilities$0$3K$19M
Total Liabilities$341K$21M$25M
— Equity —
Common Stock$3M$7M$99M
Retained Earnings-$3M-$11M-$65M
Accumulated OCI$3M$8M$3M
Total Stockholders Equity-$336K-$2M$49M
Total Liabilities & Equity$5K$18M$74M
— Key Metrics —
Total Debt$290K$19M$19M
Net Debt$289K$7M-$917K
Total Investments$0$0$301K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms